Could a Pill Replace Your CPAP?

What if treating sleep apnea started with a bedtime pill and a glass of water? This episode explores AD109, an experimental oral treatment designed to help keep the upper airway open by targeting the nerve signals that control its muscles. Drawing on research originating at Brigham and Women’s Hospital and Harvard Medical School, we unpack why airway anatomy is only part of the story—and how the combination of atomoxetine and aroxybutynin could offer another option for people who struggle with CPAP. We follow the science into the SynAIRgy and LunAIRo clinical trials, examining reductions in breathing interruptions and overnight oxygen deprivation alongside the harder questions: side effects, treatment discontinuation, residual apnea, and whether better numbers translate into feeling more rested. We also explore how this approach differs from weight-loss treatments such as Zepbound and what remains at stake in FDA review. Could the future bring a pill that replaces the mask for some patients—or a combination that makes treatment easier to live with?